🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
1. To demonstrate the feasibility of leukapheresis and ex vivo activation o...
Status
Completed
Location
National University Hospital
Start Date
2007-05
Trial ID
NCT00717184
Treatments Being Tested
Traumatic brain injury (TBI) is a common condition with high degree of morb...
Status
Unknown
Location
Cambridge University Hospital NHS Trust
Start Date
2017-10
Trial ID
NCT02997371
Treatments Being Tested
In this i-SABR (immunotherapy + Stereotactic Ablative Body Radiation) trial...
Status
Completed
Location
University of Texas Southwestern Medical Center
Start Date
2013-10-02
Trial ID
NCT01896271
Treatments Being Tested
IL-22 is an IL-10 family cytokine that plays major actions to increase inte...
Status
Completed
Location
CHU de Nantes
Start Date
2014-08
Trial ID
NCT02847052
Treatments Being Tested
Monoclonal antibodies can locate tumor cells and either kill them or delive...
Status
Completed
Location
Children's Oncology Group
Start Date
2001-01
Trial ID
NCT00005576
Treatments Being Tested
The study investigates inflammatory and antiinflammatory response in patien...
Status
Completed
Location
Dep. Anesthesiology and Pain Therapy
Start Date
2012-06
Trial ID
NCT02324140
Treatments Being Tested
The goal of the Phase I part of this clinical research study is to find the...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2013-02
Trial ID
NCT01409174
Treatments Being Tested
This research study is studying the combination of anakinra and axicabtagen...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2020-10-01
Trial ID
NCT04150913
Treatments Being Tested
This phase I clinical trial evaluates the safety and feasibility of adminis...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2017-07-26
Trial ID
NCT03240861
The purpose is to identify a dose of SB-485232 which is safe, tolerable and...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07-31
Trial ID
NCT00500058